Skip to main content Back to Top


Vitamin E Aqueous Oral Solution

Products Affected - Description

    • Aquasol E drops, Pfizer, 15 IU/0.3 mL, 12 mL bottle, 1 count, NDC 61703-0419-77
    • Aquasol E drops, Pfizer, 15 IU/0.3 mL, 30 mL bottle, 1 count, NDC 61703-0419-78
    • Aqueous Vitamin E oral drops, Lannett, 15 IU/0.3 mL, 30 mL bottle, 1 count, NDC 54838-0005-30
    • Vitamin E oral drops, Geritrex, 15 IU/0.3 mL, 12 mL bottle, 1 count, UPC 92771-072512

Reason for the Shortage

    • Geritrex discontinued vitamin E oral drops in January 2017.
    • Pfizer (Hospira) discontinued Aquasol E oral drops in October 2016.
    • Lannett (Silarx) discontinued vitamin E oral drops in July 2016.

Estimated Resupply Dates

    • Lannett and Geritrex discontinued vitamin E aqueous oral solution. Hospira discontinued Aquasol E oral solution.


Updated January 25, 2017 by Leslie Jensen, PharmD, Drug Information Specialist. Created October 2, 2012 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins